Leukemogenic Tyrosine Kinases Inhibit PKM2 to Promote the Warburg Effect and Tumor Growth
Year: 2010
Type: article
Source: Blood
Authors: Taro Hitosugi, Sumin Kang, Matthew Vander Heiden, Tea-wook Chung, Shannon Elf, Katherine Lythgoe, Shaozhong Dong, Sagar Lonial, Xu Wang, Georgia Chen, Jianxin Xie, Ting-Lei Gu, Roberto Polakiewicz, Johannes L. Roesel, Titus Boggon, Fadlo Khuri, D. Gary Gilliland, Lewis Cantley, Jonathan L. Kaufman, Jing Chen
Institutions: Emory University, Winship Cancer Institute, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Cell Signaling Technology (United States), Novartis (Switzerland), Novartis Institutes for BioMedical Research, Yale University, Merck & Co., Inc., Rahway, NJ, USA (United States), Beth Israel Deaconess Medical Center, Harvard University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2556333180